Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03983434 · ClinicalTrials.gov registry record · NA

Irritable Bowel Syndrome and Control Volunteers: Diet Challenge

A NA study, sponsored by Indiana University.

Terminated
Registry status
NA
Development phase
29
Enrollment target

NCT03983434: Clinical Trial NA study, sponsored by Indiana University.

NCT03983434 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03983434, a NA study, was terminated before completion, sponsored by Indiana University.

TERMINATED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

The purpose of this study is to study the relationship between the bile acids, short chain fatty acids and bacteria within the intestines. The hypothesis is that changes in the bacterial composition of the stool are associated with the differences in bile acids and short chain fatty acids in patients having irritable bowel syndrome compared to healthy individuals.

Primary Outcome

Stool samples will be collected over 2 days for measurement of fecal bile acids (mcmol/48h) by high performance liquid chromatography-mass spectometry

Interventions

  • DIETARY_SUPPLEMENT Inulin

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2019-08-13
Est. Completion 2023-07-31
Phase NA
Indiana University

890 total trials

Why NCT03983434 stopped before completion

NCT03983434 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Inulin is the first listed.

NCT03983434 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03983434 about?

NCT03983434 is a clinical study titled "Irritable Bowel Syndrome and Control Volunteers: Diet Challenge". The purpose of this study is to study the relationship between the bile acids, short chain fatty acids and bacteria within the intestines. The hypothesis is that changes in the bacterial composition of the stool are associated with the differences in bile acids and short chain fatty acids in patient...

What is the current status of trial NCT03983434?

This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2019-08-13. Estimated completion is 2023-07-31.

What interventions are being tested in trial NCT03983434?

The interventions under investigation include: Inulin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03983434?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03983434's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03983434, the US trial registry maintained by the National Library of Medicine. NCT03983434 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.